Helen Poulson

Helen Poulson

Associate
London

Email helen.poulson@​hoganlovells.com

Phone +44 20 7296 5453

Fax +44 20 7296 2001

LanguagesEnglish

Practice groupIntellectual Property

Helen Poulson works on multi-jurisdictional, contentious and non-contentious patent matters. She has represented international clients from the life sciences, chemicals and technology, media & telecommunications sectors. Her experience includes advising on patent litigation proceedings in the High Court (Patents Court), as well as working on disputes involving licences and/or other commercial contracts. As for non-contentious work, she has advised on complex patent portfolio and SPC issues. 

Helen complements her legal expertise with a scientific training. She graduated from Imperial College London with a First Class Honours Biochemistry degree. Prior to making the move into law, she lectured biochemistry at Nottingham Trent University.

Helen trained at Hogan Lovells during which she undertook placements of six months in Intellectual Property, International Arbitration and Pensions. She spent six months working in the in-house legal team of an international bank as part of her training.

Education and admissions

Education

Legal Practice Course, BPP Law School, Distinction, 2016

Graduate Diploma in Law, BPP Law School, Distinction, 2014

B.Sc. Biochemistry, Imperial College London, First Class Honours, 2013

Memberships

IPSoc Society for junior IP practitioners

Associate of the Royal College of Science

Representative experience

Advising Anan Kasei (part of Solvay group), a multinational specialty chemicals company, on a cross-border patent dispute relating to catalyst/co-catalyst materials for automotive emission control.

Acting for a global pharmaceutical company on appealing the EPO's Opposition Division decision in relation to its patent for a cancer therapeutic.

Advising a global telecommunications company in UK litigation concerning patent entitlement and breach of contract issues, including coordination with European proceedings.

Advising international equity fund on validity, SPC, regulatory and infringement issues arising from patents relating to a tyrosine kinase inhibitor.

Loading data